Abstract:
An apparatus and method for manufacturing articles made of polyurethane that includes a mold assembly in communication with a mix chamber. The mix chamber is positioned below the mold assembly. The mix chamber includes a propeller for mixing the liquid polyurethane chemicals. The mix chamber further includes a pneumatically actuated bladder that causes the mixed chemicals to move from the mix chamber to the mold assembly. The chemicals expand to take on the shape of the mold. The method of the present invention comprises the steps of: (a) selecting polyurethane chemicals having certain specific weights; (b) placing said chemicals in a mix chamber wherein chemicals stratify according to their specific weights to prevent detrimental reaction among the chemicals until final mixing; and (c) allowing the chemicals to expand to form an article.
Abstract:
A portable oxygen concentrator includes a reservoir adapted to store oxygen-enriched gas, a delivery valve adapted to communicate with the reservoir, a pressure sensor adapted to measure a reservoir pressure within the reservoir and to measure a pressure drop across the delivery valve, and an input device adapted to receive a pulse does setting. A controller coupled to the pressure sensor and monitors the reservoir pressure and the pressure drop across the delivery valve. The controller is also coupled to the delivery valve to selectively open the delivery valve for pulse durations based on the pulse dose setting to deliver pulses of gas from the reservoir to a user. The controller further adjusts the pulse durations based at least partially upon the reservoir pressure and the pressure drop across the delivery valve.
Abstract:
Compounds of formula I ##STR1## wherein G, J, L, M, m and D have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
Abstract:
Compounds of formula I ##STR1## wherein Q.sup.1, Q.sup.2, Q.sup.3, and Q.sup.4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.